BR7600206A - Processo para obter uma preparacao estavel de insulina de acao prolongada,bem como composicao e processo terapeuticos - Google Patents

Processo para obter uma preparacao estavel de insulina de acao prolongada,bem como composicao e processo terapeuticos

Info

Publication number
BR7600206A
BR7600206A BR7600206A BR7600206A BR7600206A BR 7600206 A BR7600206 A BR 7600206A BR 7600206 A BR7600206 A BR 7600206A BR 7600206 A BR7600206 A BR 7600206A BR 7600206 A BR7600206 A BR 7600206A
Authority
BR
Brazil
Prior art keywords
composition
well
obtain stable
prolonged action
stable preparation
Prior art date
Application number
BR7600206A
Other languages
English (en)
Portuguese (pt)
Inventor
B Hansen
F Andresen
Original Assignee
Nordisk Insulinlab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nordisk Insulinlab filed Critical Nordisk Insulinlab
Publication of BR7600206A publication Critical patent/BR7600206A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • C07K14/625Extraction from natural sources
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
BR7600206A 1975-01-15 1976-01-14 Processo para obter uma preparacao estavel de insulina de acao prolongada,bem como composicao e processo terapeuticos BR7600206A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK8375AA DK140801B (da) 1975-01-15 1975-01-15 Fremgangsmåde til fremstilling af et stabilt langtidsvirkende insulinpræparat.

Publications (1)

Publication Number Publication Date
BR7600206A true BR7600206A (pt) 1976-08-31

Family

ID=8089535

Family Applications (1)

Application Number Title Priority Date Filing Date
BR7600206A BR7600206A (pt) 1975-01-15 1976-01-14 Processo para obter uma preparacao estavel de insulina de acao prolongada,bem como composicao e processo terapeuticos

Country Status (36)

Country Link
JP (1) JPS5946939B2 (enExample)
AR (1) AR213088A1 (enExample)
AT (1) AT362492B (enExample)
BE (1) BE837600A (enExample)
BR (1) BR7600206A (enExample)
CA (1) CA1094549A (enExample)
CH (1) CH631625A5 (enExample)
CS (1) CS208147B2 (enExample)
DD (1) DD124379A5 (enExample)
DE (1) DE2600971C2 (enExample)
DK (1) DK140801B (enExample)
EG (1) EG11988A (enExample)
ES (1) ES444558A1 (enExample)
FI (1) FI66751C (enExample)
FR (1) FR2297634A1 (enExample)
GB (1) GB1524431A (enExample)
GR (1) GR58608B (enExample)
HU (1) HU175142B (enExample)
IE (1) IE42395B1 (enExample)
IL (1) IL48845A (enExample)
IN (1) IN143279B (enExample)
IT (1) IT1054211B (enExample)
KE (1) KE2919A (enExample)
LU (1) LU74175A1 (enExample)
MX (1) MX4052E (enExample)
MY (1) MY7900169A (enExample)
NL (1) NL166464C (enExample)
NO (1) NO146698C (enExample)
NZ (1) NZ179733A (enExample)
OA (1) OA05209A (enExample)
PL (1) PL99927B1 (enExample)
PT (1) PT64696B (enExample)
RO (1) RO71576A (enExample)
SE (1) SE437219B (enExample)
YU (1) YU8376A (enExample)
ZA (1) ZA7658B (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK374579A (da) * 1979-09-07 1981-03-08 Nordisk Insulinlab Fremgangsmaade til fremstilling af et injucerbart insulinpraeparat
US4459226A (en) * 1982-02-26 1984-07-10 Eli Lilly And Company Process for recovering insulin
US4801575A (en) * 1986-07-30 1989-01-31 The Regents Of The University Of California Chimeric peptides for neuropeptide delivery through the blood-brain barrier
US4878892A (en) * 1987-02-10 1989-11-07 Drug Delivery Systems Inc. Electrolytic transdermal delivery of polypeptides
AU609769B2 (en) * 1987-02-10 1991-05-09 Drug Delivery Systems Inc. Electrolytic transdermal delivery of proteins
US6221367B1 (en) 1992-06-15 2001-04-24 Emisphere Technologies, Inc. Active agent transport systems
US5629020A (en) * 1994-04-22 1997-05-13 Emisphere Technologies, Inc. Modified amino acids for drug delivery
US5714167A (en) 1992-06-15 1998-02-03 Emisphere Technologies, Inc. Active agent transport systems
US5447728A (en) 1992-06-15 1995-09-05 Emisphere Technologies, Inc. Desferrioxamine oral delivery system
US5643957A (en) 1993-04-22 1997-07-01 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5750147A (en) 1995-06-07 1998-05-12 Emisphere Technologies, Inc. Method of solubilizing and encapsulating itraconazole
US6051258A (en) 1995-06-07 2000-04-18 Emisphere Technologies, Inc. Proteinoid emulsions and methods for preparation and use thereof
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
EP2414560B1 (de) 2009-03-31 2013-10-23 Boehringer Ingelheim International GmbH Verfahren zur beschichtung einer oberfläche eines bauteils
EP3508239B1 (de) 2009-05-18 2020-12-23 Boehringer Ingelheim International GmbH Adapter, inhalationseinrichtung und zerstäuber
JP5658268B2 (ja) 2009-11-25 2015-01-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
MX2012005961A (es) 2009-11-25 2012-06-14 Boehringer Ingelheim Int Nebulizador.
JP5874724B2 (ja) 2010-06-24 2016-03-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
WO2012130757A1 (de) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
EP2835146B1 (en) 2013-08-09 2020-09-30 Boehringer Ingelheim International GmbH Nebulizer
WO2015018904A1 (en) 2013-08-09 2015-02-12 Boehringer Ingelheim International Gmbh Nebulizer
MX383195B (es) 2014-05-07 2025-03-13 Boehringer Ingelheim Int Recipiente, nebulizador y uso.
BR122022010094B1 (pt) 2014-05-07 2023-10-03 Boehringer Ingelheim International Gmbh Dispositivo indicador e recipiente
WO2015169430A1 (en) 2014-05-07 2015-11-12 Boehringer Ingelheim International Gmbh Nebulizer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1285023A (en) * 1968-08-09 1972-08-09 Novo Terapeutisk Labor As Improvements in or relating to injectable insulin preparations
US3758683A (en) * 1971-04-30 1973-09-11 R Jackson Insulin product

Also Published As

Publication number Publication date
GR58608B (en) 1977-11-10
FI66751C (fi) 1984-12-10
HU175142B (hu) 1980-05-28
AU1030776A (en) 1977-07-21
AR213088A1 (es) 1978-12-15
NZ179733A (en) 1978-04-28
NL166464C (nl) 1981-08-17
NL166464B (nl) 1981-03-16
CH631625A5 (en) 1982-08-31
IE42395L (en) 1976-07-15
DK140801C (enExample) 1980-04-21
BE837600A (fr) 1976-07-15
DE2600971C2 (de) 1985-12-12
KE2919A (en) 1979-03-30
MY7900169A (en) 1979-12-31
MX4052E (es) 1981-11-24
PT64696A (fr) 1976-02-01
RO71576A (ro) 1980-12-30
DK8375A (enExample) 1976-07-16
CA1094549A (en) 1981-01-27
ZA7658B (en) 1976-12-29
JPS51125299A (en) 1976-11-01
SE7600284L (sv) 1976-07-16
YU8376A (en) 1982-06-30
NO146698B (no) 1982-08-16
FI760058A7 (enExample) 1976-07-16
ES444558A1 (es) 1977-05-16
OA05209A (fr) 1981-02-28
PL99927B1 (pl) 1978-08-31
JPS5946939B2 (ja) 1984-11-15
SE437219B (sv) 1985-02-18
FR2297634A1 (fr) 1976-08-13
IT1054211B (it) 1981-11-10
DE2600971A1 (de) 1976-07-22
EG11988A (en) 1978-06-30
DD124379A5 (enExample) 1977-02-16
CS208147B2 (en) 1981-08-31
ATA21376A (de) 1980-10-15
IL48845A0 (en) 1976-03-31
PT64696B (fr) 1977-08-10
LU74175A1 (enExample) 1977-03-18
IL48845A (en) 1981-06-29
IN143279B (enExample) 1977-10-29
NL7600338A (nl) 1976-07-19
FR2297634B1 (enExample) 1979-03-30
DK140801B (da) 1979-11-19
NO146698C (no) 1982-11-24
IE42395B1 (en) 1980-07-30
FI66751B (fi) 1984-08-31
NO760118L (enExample) 1976-07-16
GB1524431A (en) 1978-09-13
AT362492B (de) 1981-05-25

Similar Documents

Publication Publication Date Title
BR7604361A (pt) Novos polimeros quaternizados,processo para sua preparacao,sua aplicacao e composicoes bem como processo cosmeticos
IT1061318B (it) Composizioni di carburi cementati e metodo per produrle
BR7602666A (pt) Estrutura de malha e processo para fabricar uma peca de vestuario
IT7849523A0 (it) 3-1h-tetrazol-5-il-4h-pirido 1,2-a pirimidin-4-oni sostituiti utili in particolare come agenti terapeutici per inibire le reazioni allergiche e procedimento per la produzione dei detti derivati
BR7801931A (pt) Processo e composicao para tratar cabelo
MX5334E (es) Procedimiento para reducir la concentracion de nitrosaminas en dinitroanilinas
BE835224A (fr) Nouveaux derives piperidylideniques, leur procede de preparation et leur usage therapeutique
BR7606983A (pt) Processo para produzir uma composicao explosiva de gel aquoso estavel e composicao explosiva de gel aquoso estavel
BR6915173D0 (pt) Processo para preparar uma composicao anestesica
BR7802327A (pt) Processo para produzir um eletrodo e eletrodo
SE7609100L (sv) Hudbehandlingskomposition
IT1039756B (it) Procedimento per migliopare l at tivita di enzimi ossidoriduttasici inglobati in strutture filamentose
BR7105702D0 (pt) Um cigarro aperfeicoado e processo de tratamento de um cigarro para reduzir a producao de constituintes de fumaca
BR7106230D0 (pt) Processo para preparar novos derivados vinil fosforicos bem como composicoes pesticidas neles baseadas
IT1092754B (it) Procedimento per evitare la formazione di cascame nella produzione di vello
AR211926A1 (es) Derivados de cis-3-aminometil-2-fenil-biciclo-2,2,2-octano desprovistos de actividad terapeutica,utiles como intermediarios para preparar productos terapeuticos
BR7402819D0 (pt) Composicao de poliuretano estabilizado e processo para estabilizar poliuretano
BR7107498D0 (pt) Processo para preparar uma composicao antipersistente aperfeicoada de curonol estavel
MX150898A (es) Procedimiento mejorado de amoxidacion para la obtencion de nitrilos
BR7606606A (pt) Composicoes e processo para combater seletivamente plantas daninhas em cereais,bem como processo para a preparacao das composicoes
NL7806664A (nl) Intraveneus toe te dienen waterige oplossing en zijn bereiding.
BR7608427A (pt) Processo para tratamento de dente,bem como composicao catalisada e composicoes para obtencao da ultima
BR7502358A (pt) Processo para preparar compostos, bem como processo e composicao para a protecao da pele contra a luz
BR7501692A (pt) Processo para a preparacao de derivados difosforados ciclicos bem como composicoes fungicidas e processo para o trattamento das plantas
BR7602797A (pt) Composicao cataliticamente ativa e processo para preparar esta composicao